Seres Therapeutics Inc (MCRB)
0.8485
+0.01
(+1.35%)
USD |
NASDAQ |
Oct 04, 16:00
0.8509
0.00 (0.00%)
After-Hours: 20:00
Seres Therapeutics Shareholders Equity (Annual): -44.86M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -44.86M |
| December 31, 2022 | 10.78M |
| December 31, 2021 | 131.51M |
| December 31, 2020 | 174.75M |
| December 31, 2019 | -48.32M |
| December 31, 2018 | -48.04M |
| Date | Value |
|---|---|
| December 31, 2017 | 60.70M |
| December 31, 2016 | 132.63M |
| December 31, 2015 | 205.39M |
| December 31, 2014 | -26.72M |
| December 31, 2013 | -11.12M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-48.32M
Minimum
2019
174.75M
Maximum
2020
44.77M
Average
10.78M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Chimerix Inc | 193.03M |
| Marinus Pharmaceuticals Inc | 16.76M |
| Jaguar Health Inc | 4.961M |
| PDS Biotechnology Corp | 26.13M |
| Mersana Therapeutics Inc | 36.90M |